Variable | Base-case analysis | Sensitivity analysis | Reference | ||
---|---|---|---|---|---|
FIT-screening | National monitor of the Dutch CRC screening program [29, 34] | ||||
Participation FIT | 0.73 | ||||
Adherence to FIT-positive colonoscopy | 0.92 | ||||
Adherence to surveillance colonoscopy | 0.92 | ||||
Primary colonoscopy screening | |||||
Adherence to screening colonoscopy | 0.22 | ||||
Adherence to surveillance colonoscopy | 0.92 | ||||
FIT positivity rate per lesion | Men | Women | Men | Women | [31] |
Healthy | 0.96a | 0.97a | |||
Diminutive adenoma | 0.004 | 0.003 | |||
Small adenoma | 0.12 | 0.10 | |||
Large adenoma | 0.30 | 0.28 | |||
Small SP | 0.004 | 0.003 | 0.06 | 0.05 | |
Large SP | 0.004 | 0.003 | 0.30 | 0.28 | |
Early stage CRC | 0.50 | 0.50 | |||
Late stage CRC | 0.85 | 0.85 | |||
Contribution of serrated pathway to CRC incidence | 15% | 30% | [12] | ||
Complications after colonoscopy | 0.0028 | ||||
Fatal complications after colonoscopy | 0.0001 |